Gynecologic cancer interGroup (GCIG) consensus review for ovarian small cell cancers

  • Nicholas Simon Reed
  • , Patricia Pautier
  • , Elizabeth Åvall-Lundqvist
  • , Chel Hun Choi
  • , Andreas Du Bois
  • , Michael Friedlander
  • , Anthony Fyles
  • , Ganessan Kichenadasse
  • , Diane M. Provencher
  • , Isabelle Ray-Coquard

Research output: Contribution to journalReview articlepeer-review

Abstract

Small cell carcinomas of the ovary are uncommon and account for less than 1% of ovarian cancers. They were first recognized in 1979, and a number of reports appeared during the next 2 decades. They are highly aggressive tumors and usually carry a poor prognosis, although this may reflect that most are diagnosed at advanced stage; however, those diagnosed as stage 1A have only 30% to 40% of long-Term survivors. More reports followed extending our experience in the diagnosis and management of these rare cancers. The classification is described below and shown in Table 1, but a revision is expected to be published from the World Health Organization in 2014.

Original languageEnglish
Pages (from-to)S30-S34
JournalInternational Journal of Gynecological Cancer
Volume24
Issue number9
DOIs
StatePublished - Nov 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chemotherapy
  • Hypercalcaemia
  • Pulmonary type
  • Radiation therapy
  • Rare cancers
  • Small cell carcinoma ovary
  • Surgery

Fingerprint

Dive into the research topics of 'Gynecologic cancer interGroup (GCIG) consensus review for ovarian small cell cancers'. Together they form a unique fingerprint.

Cite this